Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
56.2M
-
Number of holders
-
422
-
Total 13F shares, excl. options
-
46.3M
-
Shares change
-
+773K
-
Total reported value, excl. options
-
$9.25B
-
Value change
-
+$157M
-
Put/Call ratio
-
0.75
-
Number of buys
-
174
-
Number of sells
-
-238
-
Price
-
$199.62
Significant Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q2 2021
518 filings reported holding RGEN - REPLIGEN CORP - COMMON STOCK as of Q2 2021.
REPLIGEN CORP - COMMON STOCK (RGEN) has 422 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.3M shares
of 56.2M outstanding shares and own 82.4% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.31M shares), VANGUARD GROUP INC (4.89M shares), Invesco Ltd. (2.34M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.76M shares), FRED ALGER MANAGEMENT, LLC (1.39M shares), STATE STREET CORP (1.31M shares), Select Equity Group, L.P. (1.3M shares), ALLIANCEBERNSTEIN L.P. (1.27M shares), 12 West Capital Management LP (1.08M shares), and Conestoga Capital Advisors, LLC (1.02M shares).
This table shows the top 422 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.